Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Cancer Epidemiol. 2020 Sep 30;69:101826. doi: 10.1016/j.canep.2020.101826

Table 2.

Conditional logistic regression analysis to identify metabolites significantly associated with breast cancer

Model 1* Model 2#

Metabolites Pathways Sub-pathways OR (95% CI) P value OR (95% CI) P value
3-hydroxyoctanoate Lipid Fatty Acid, Monohydroxy 1.55 (1.13, 3.32) 0.016 1.51 (1.10, 3.47) 0.022
3-hydroxybutyrate (BHBA) Lipid Ketone Bodies 1.47 (1.11, 3.72) 0.020 1.42 (1.01, 3.72) 0.049
stearate (18:0) Lipid Long Chain Fatty Acid 1.22 (0.83, 4.01) 0.235 1.26 (0.79, 4.24) 0.332
3-hydroxydecanoate Lipid Fatty Acid, Monohydroxy 1.29 (0.87, 4.09) 0.203 1.35 (0.86, 4.27) 0.194
linoleate (18:2n6) Lipid Polyunsaturated Fatty Acid (n3 and n6) 1.38 (1.06, 3.93) 0.043 1.39 (1.07, 4.04) 0.041
10-nonadecenoate (19:ln9) Lipid Long Chain Fatty Acid 1.33 (1.05, 4.04) 0.044 1.30 (0.96, 4.14) 0.060
dihomo-linoleate Lipid Polyunsaturated Fatty Acid (n3 and n6) 1.20 (0.73, 3.99) 0.589 1.15 (0.63, 4.02) 0.764
3-methylxanthine Xenobiotics Xanthine Metabolism Hemoglobin and Porphyrin 0.80 (0.32, 2.80) 0.504 0.85 (0.33, 3.51) 0.619
bilirubin Cofactors/Vitamins Metabolism 0.50 (0.47, 0.90) 0.034 0.54 (0.42, 0.95) 0.041
1-palmitoyl-GPA (16:0) glucuronate Lipid Lysolipid 0.89 (0.45, 3.16) 0.744 0.90 (0.40, 3.81) 0.778
Carbohydrate Aminosugar Metabolism 0.90 (0.32, 4.53) 0.796 0.95 (0.33, 4.72) 0.904
1-(1-enyl-stearoyl)-2-dihomo-linolenoyl-GPE Lipid Plasmalogen Urea cycle; Arginine and Proline 0.62 (0.33, 1.25) 0.146 0.70 (0.35, 1.30) 0.166
urea Amino Acid Metabolism 1.11 (0.59, 4.08) 0.646 1.12 (0.58, 4.16) 0.639
sphingomyelin Lipid Sphingolipid Metabolism 0.90 (0.41, 4.28) 0.826 0.92 (0.34, 4.51) 0.854
*.

Adjusted by parity, education, birth place, language acculturation, and BMI category.

#.

Adjusted by parity, education, birth place, language acculturation, and BMI category, smoking status, alcohol status, sitting time, and physical activity.